the sensitivities to 1-beta-d-arabinofuranosylcytosine ( ara-c ) and n4-behenoyl-1-beta-d-arabinofuranosylcytosine ( bh-ac ) , a masked compound of ara-c , were determined in 33 human tumor tissues ( 11 gastric , 6 colorectal cancers and 16 malignant lymphomas ) , using the in vitro succinate dehydrogenase inhibition test .
C0010711
arabinofuranosylcytosine
C0024299
malignant lymphomas